Cargando…

Necrosis in non-tumour tissues caused by flavone acetic acid and 5,6-dimethyl xanthenone acetic acid.

Detalles Bibliográficos
Autores principales:	Zwi, L. J., Baguley, B. C., Gavin, J. B., Wilson, W. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971574/ https://www.ncbi.nlm.nih.gov/pubmed/2257222

Ejemplares similares

The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels.
por: Zwi, L. J., et al.
Publicado: (1990)

Antitumour responses to flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid in immune deficient mice.
por: Ching, L. M., et al.
Publicado: (1992)

Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid.
por: Ching, L. M., et al.
Publicado: (1995)

Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs.
por: Lash, C. J., et al.
Publicado: (1998)

Thalidomide increases both intra-tumoural tumour necrosis factor-α production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid
por: Cao, Z, et al.
Publicado: (1999)

Flavone acetic acid induces a coagulopathy in mice.
por: Murray, J. C., et al.
Publicado: (1989)

Production of tumour necrosis factor-alpha by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).
por: Philpott, M., et al.
Publicado: (1997)

Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid).
por: Bibby, M. C., et al.
Publicado: (1987)

Anticoagulant treatment does not affect the action of flavone acetic acid in tumour-bearing mice.
por: Thurston, G., et al.
Publicado: (1991)

Tumour concentrations of flavone acetic acid (FAA) in human melanoma: comparison with mouse data.
por: Maughan, T. S., et al.
Publicado: (1992)

Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity.
por: Ching, L. M., et al.
Publicado: (1998)

Divergent effects of flavone acetic acid on established versus developing tumour blood flow.
por: Mahadevan, V., et al.
Publicado: (1991)

Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512).
por: Bibby, M. C., et al.
Publicado: (1988)

Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.
por: Bibby, M. C., et al.
Publicado: (1991)

Induction of endothelial cell apoptosis by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid
por: Ching, L-M, et al.
Publicado: (2002)

The relationship between tissue levels of flavone acetic acid (NSC 347512) and site dependent anti-tumour activity in murine colon tumours.
por: Bibby, M. C., et al.
Publicado: (1991)

Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. IV: Pharmacokinetics and toxicity of flavone acetic acid and its metabolites.
por: Stratford, M. R., et al.
Publicado: (1993)

Flavone acetic acid (FAA) with recombinant interleukin-2 (TIL-2) in advanced malignant melanoma. II: Induction of nitric oxide production.
por: Thomsen, L. L., et al.
Publicado: (1992)

The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice
por: Zhao, L, et al.
Publicado: (2002)

Response of chemically induced primary colon tumours of the mouse to flavone acetic acid (NSC 347 512).
por: Pratesi, G., et al.
Publicado: (1988)

Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma.
por: Kerr, D. J., et al.
Publicado: (1989)

Flavone acetic acid--an interesting novel therapeutic agent or just another disappointment?
por: Bibby, M. C.
Publicado: (1991)

Vadimezan: 2-(5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid
por: Zhang, Shi-Jie, et al.
Publicado: (2010)

Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts.
por: Giavazzi, R., et al.
Publicado: (1988)

Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid.
por: Laws, A. L., et al.
Publicado: (1995)

Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent
por: Jameson, M B, et al.
Publicado: (2003)

Flavonoid-Inspired Vascular Disrupting Agents: Exploring Flavone-8-Acetic Acid and Derivatives in the New Century
por: Gobbi, Silvia, et al.
Publicado: (2021)

Flavone acetic acid induces a G2/M cell cycle arrest in mammary carcinoma cells
por: Panaro, N J, et al.
Publicado: (1999)

Differential efficacy of flavone acetic against liver versus lung metastases in a human tumour xenograft.
por: Pratesi, G., et al.
Publicado: (1991)

Bis(3,5-dimethylpyrazol-1-yl)acetic acid
por: Nguyen, Quang Trung, et al.
Publicado: (2007)

Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: immunological studies.
por: Ghosh, A. K., et al.
Publicado: (1990)

Persistent induction of nitric oxide synthase in tumours from mice treated with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid.
por: Moilanen, E., et al.
Publicado: (1998)

(E)-2-(3-Cinnamoylthioureido)acetic acid dimethyl sulfoxide disolvate
por: Hassan, Ibrahim N., et al.
Publicado: (2011)

Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: a phase II study.
por: Thatcher, N., et al.
Publicado: (1990)

Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. III: Cytokine studies.
por: Haworth, C., et al.
Publicado: (1993)

Acetic Acid in Cholera
por: Chandra, R. C.
Publicado: (1866)

Acetic Acid in Erysipelas
por: Hauser, Wm.
Publicado: (1859)

Chlor-Acetic Acid in Cancer
por: Bumstead, S. J.
Publicado: (1879)

Cytenamide acetic acid solvate
por: Johnston, Andrea, et al.
Publicado: (2008)

Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma: I. Clinical and vascular studies.
por: O'Reilly, S. M., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_c38a8l3gecfkan25u9e8a3es30